Management and treatment of glomerular diseases ( part 2 ) : conclusions from a Kidney Disease : Conference

Conference Brad H. Rovin, Dawn J. Caster, Daniel C. Cattran, Keisha L. Gibson, Jonathan J. Hogan, Marcus J. Moeller, Dario Roccatello, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer and Jürgen Floege; for Conference Participants Division of Nephrology, The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA; Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky, USA; Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada; University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, North Carolina, USA; Division of Nephrology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule, University of Aachen, Aachen, Germany; CMID (Center of Research of Immunopathology and Rare Diseases), and Division of Nephrology and Dialysis (ERK-Net member), University of Turin, Italy; KDIGO, Brussels, Belgium; University College London, London, UK; Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; and Division of Nephrology, Rheinisch-Westfälische Technische Hochschule, University of Aachen, Aachen, Germany